Sargramostim (1) – Imreplys®
Sargramostim (1)
Characteristics
| Start date | 21.07.2025 |
|---|---|
| Resolution | 18.09.2025 |
| INN | Sargramostim |
| Brand name | Imreplys® |
| Pharm. company | Partner Therapeutics Ltd |
| G-BA Procedure ID | F-002 |
| Therapeutic area | n.d. |
| Reason for procedure | not completed: exempted |
Associated procedures
<< List of all resolutions